Stockreport

Zentalis Pharmaceuticals Announces Pricing of Underwritten Offering of Common Stock

Zentalis Pharmaceuticals, Inc. - common stock  (ZNTL) 
PDF NEW YORK and SAN DIEGO, May 16, 2022 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discoveri [Read more]